Anti-malaria drug hydroxychloroquine's coronavirus trials to resume, says WHO

Anti-malaria drug hydroxychloroquine will be once again tested for its effectiveness against the novel coronavirus as the World Health Organization has decided to resume its trials under the Solidarity Trials. Last week, the WHO had suspended the trials for hydroxychloroquine as concerns were raised about the safety of the drug.